BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
8 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive ctDNA Measurements Improve Prediction of clinical outcomes and Enable Dynamic Tracking of Disease Progression in Advanced pancreatic cancer.
    Lapin M; Edland KH; Tjensvoll K; Oltedal S; Austdal M; Garresori H; Rozenholc Y; Gilje B; NordgÄrd O
    Clin Cancer Res; 2023 Apr; 29(7):1267-1278. PubMed ID: 36662807
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve clinical cancer Care.
    Chakraborty S; Ecker BL; Seier K; Aveson VG; Balachandran VP; Drebin JA; D'Angelica MI; Kingham TP; Sigel CS; Soares KC; Vakiani E; Wei AC; Chandwani R; Gonen M; Shen R; Jarnagin WR
    Clin Cancer Res; 2021 Nov; 27(21):5891-5899. PubMed ID: 34433650
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy.
    Sakai A; Tsujimae M; Masuda A; Iemoto T; Ashina S; Yamakawa K; Tanaka T; Tanaka S; Yamada Y; Nakano R; Sato Y; Kurosawa M; Ikegawa T; Fujigaki S; Kobayashi T; Shiomi H; Arisaka Y; Itoh T; Kodama Y
    World J Gastroenterol; 2019 Mar; 25(11):1387-1397. PubMed ID: 30918431
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Flanagan DJ; Barker N; Costanzo NSD; Mason EA; Gurney A; Meniel VS; Koushyar S; Austin CR; Ernst M; Pearson HB; Boussioutas A; Clevers H; Phesse TJ; Vincan E
    Cancer Res; 2019 Mar; 79(5):970-981. PubMed ID: 30622113
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
    Imaoka H; Kou T; Tanaka M; Egawa S; Mizuno N; Hijioka S; Hara K; Yazumi S; Shimizu Y; Yamao K
    Eur J Cancer; 2016 Feb; 54():96-103. PubMed ID: 26741729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CD24 and apc Genetic Polymorphisms in pancreatic cancers as Potential Biomarkers for clinical outcome.
    Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
    PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
    Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
    Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.